Commission Actions

The Commission has received an application for approval of a proposed divestiture from ConocoPhillips, Inc. (ConocoPhillips), pursuant to a final decision and order with the FTC, announced on February...

Case Timeline Item

Phillips Petroleum Co. and Conoco Inc. (timeline item) - March 14, 2003

Date

14 de Mar de 2003

Petition of ConocoPhillips for Approval of the Proposed Divestiture of The Phillips Spokane Terminal to Holly Corporation (943.23 KB)

Case Timeline Item

Chicago Bridge & Iron Company N.V., Chicago Bridge & Iron Company, and Pitt-Des Moines, Inc., In the Matter of (timeline item) - March 14, 2003

Date

14 de Mar de 2003

Complaint Counsel's Corrected Reply Brief (1.65 MB)

13 de Mar de 2003

Federal Register Notice

Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules

Date

13 de Mar de 2003

Federal Register Notice

Bristol-Myers Squibb Company; Analysis to Aid Public Comment

Date

13 de Mar de 2003

Case Timeline Item

Rambus Inc., In the Matter of (timeline item) - March 13, 2003

Date

13 de Mar de 2003

Joint Request for Status Conference (195.01 KB)

Administrative Law Judges Order Denying Complaint Counsel's Motion to Compel an Additional Day of Deposition Testimony of Richard Crisp (34.88 KB)

Respondent Rambus Inc.s Supplemental Responses to Complaint Counsels First Request for Admissions (94.12 KB)

Reply Brief in Support of Respondents Application for Review of the February 26, 2003 Order Granting Complaint Counsels Motion for Collateral Estoppel Pursuant to Rule 3.23(b) or, in the Alternative, Request for Reconsideration of That Order (35.92 KB)

Proposed Order (5.05 KB)

Motion by Respondent Rambus Inc. for Leave to File a Reply Brief in Support of Respondents Application for Review of the February 26, 2003 Order Granting Complaint Counsels Motion for Collateral Estoppel Pursuant to Rule 3.23(b) or, in the Alternative, R (8.71 KB)

Advisory Opinions

Arkansas Children's Hospital

Date

13 de Mar de 2003

re: Sale of pharmaceuticals by non-profit children's hospital to patients seen in clinics operated by the University of Arkansas for Medical Sciences on the hospital's campus.

Advisory Opinions

Valley Baptist Medical Center

Date

13 de Mar de 2003

re: Sale of pharmaceuticals by non-profit hospital to contracted workers who provide services at the hospital

11 de Mar de 2003

Para su Difusión

Rexall Sundown to Pay up to $12 Million to Settle Charges Regarding Cellulite Treatment Product

Fecha

11 de Mar de 2003

Rexall Sundown, Inc. (Rexall) will pay up to $12 million to resolve Federal Trade Commission charges regarding its marketing of the dietary supplement, "Cellasene," a purported cellulite treatment...

Case Timeline Item

Rexall Sundown, Inc. (timeline item) - March 11, 2003

Date

11 de Mar de 2003

Complaint for Injunction and Other Equitable Relief (21.11 KB)

Stipulated Final Order for Permanent Injunction and Settlement of Claims for Monetary Relief (566.19 KB)

Case Timeline Item

Rambus Inc., In the Matter of (timeline item) - March 11, 2003

Date

11 de Mar de 2003

Response To Rambuss Application For Review Of February 26, 2003, Order Granting Complaint Counsels Motion For Collateral Estoppel Or, In The Alternative, Request For Reconsideration (69.75 KB)

Proposed Order (4.95 KB)

Memorandum by Respondent Rambus Inc. and by Third-Party Witness Richard Crisp in Opposition to Motion to Complaint Counsel's Motion to Compel an Additional Day of Testimony of Richard Crisp (34.83 KB)

10 de Mar de 2003

Case Timeline Item

Union Oil Company of California, In the Matter of (timeline item) - March 10, 2003

Date

10 de Mar de 2003

Notice of Appearance (322.63 KB)

Case Timeline Item

Rambus Inc., In the Matter of (timeline item) - March 10, 2003

Date

10 de Mar de 2003

Appendix To Application For Review Of The February 28, 2003 Order Granting Complaint Counsels Motion To Compel Discovery Relating To Subject Matters As To Which Rambuss Privilege Claims Were Invalidated On Crime-Fraud Grounds And Subsequently Waived, Pur (9.98 KB)

7 de Mar de 2003

Para su Difusión

FTC Charges Bristol-Myers Squibb with Pattern of Abusing Government Processes to Stifle Generic Drug Competition

Fecha

7 de Mar de 2003

The Federal Trade Commission today announced that Bristol-Myers Squibb Company (Bristol) - one of the world's largest drug makers - has settled charges that it engaged in a series of anticompetitive...

Case Timeline Item